Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 USD | 0.00% | +5.26% | -79.49% |
Mar. 28 | Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M | MT |
Business Summary
Number of employees: 19
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Transdermal Patch
100.0
%
| 11 | 100.0 % | 20 | 100.0 % | +80.02% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 11 | 100.0 % | 20 | 100.0 % | +80.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Scott Coiante
DFI | Director of Finance/CFO | 57 | 10-11-30 |
Paul Korner
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-08-16 |
Chief Administrative Officer | 58 | 14-07-31 | |
Matthew Riley
IRC | Investor Relations Contact | - | 20-01-01 |
Amy Welsh
PRN | Corporate Officer/Principal | 53 | 20-04-30 |
Kimberly Whelan
PRN | Corporate Officer/Principal | - | 19-11-30 |
Joseph D’Urso
AUD | Comptroller/Controller/Auditor | - | 14-09-30 |
Robert Conway
PRN | Corporate Officer/Principal | 67 | 03-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Al Altomari
CEO | Chief Executive Officer | 65 | 04-01-31 |
Seth Fischer
BRD | Director/Board Member | 68 | 16-07-27 |
John Hubbard
BRD | Director/Board Member | 67 | 14-11-17 |
Sandra A. Carson
BRD | Director/Board Member | 70 | 20-06-08 |
Director/Board Member | 58 | 21-10-06 | |
Sharon Barbari
BRD | Director/Board Member | 70 | 20-06-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,856,229 | 6,825,884 ( 99.56 %) | 0 | 99.56 % |
Stock B | 0 | 4,850 | 0 | 4,850 ( 100.00 %) |
Company contact information
Agile Therapeutics, Inc.
500 College Road East Suite 310
08540-1715, Princeton
+609 683 1880
http://www.agiletherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.49% | 2.74M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- AGRX Stock
- Company Agile Therapeutics, Inc.